Agilent Technologies Inc
NYSE:A
Agilent Technologies Inc
Cash from Financing Activities
Agilent Technologies Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Agilent Technologies Inc
NYSE:A
|
Cash from Financing Activities
$-1.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Financing Activities
$-3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Danaher Corp
NYSE:DHR
|
Cash from Financing Activities
$-273m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
16%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash from Financing Activities
$-459.6m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-57%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Financing Activities
$-859.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Financing Activities
$-382m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is Agilent Technologies Inc's Cash from Financing Activities?
Cash from Financing Activities
-1.2B
USD
Based on the financial report for Jan 31, 2024, Agilent Technologies Inc's Cash from Financing Activities amounts to -1.2B USD.
What is Agilent Technologies Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-8%
Over the last year, the Cash from Financing Activities growth was -37%. The average annual Cash from Financing Activities growth rates for Agilent Technologies Inc have been -6% over the past three years , -4% over the past five years , and -8% over the past ten years .